#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Surgical Treatment of Breast Cancer in the Masaryk Memorial Cancer Institute


Authors: O. Coufal;  V. Fait;  V. Foltinová;  P. Vrtělová;  L. Gabrielová;  V. Chrenko
Authors‘ workplace: Oddělení chirurgické onkologie, primář: MUDr. V. Chrenko, CSc. ;  Masarykův onkologický ústav, ředitel: prof. MUDr. R. Vyzula, CSc.
Published in: Rozhl. Chir., 2007, roč. 86, č. 10, s. 540-547.
Category: Monothematic special - Original

Overview

Breast cancer represents the most frequent malignancy in women in the Czech Republic. Although surgery plays the basic role in the therapy of its early stages there hasn’t existed any specialized training in surgical oncology in our country so far. Majority of patients are surgically treated at departments of general surgery where sometimes outdated procedures are used as we know from our own experience.

In the Masaryk Memorial Cancer Institute we perform approximately 500 breast surgeries a year and provide a team of surgeons specialised in this field.

The aim of our article is to give a basic review of modern techniques in breast cancer surgery, to describe more precisely the most frequent ones and to give a list of some relevant literary sources.

Key words:
breast cancer – surgical oncology – mastectomy – sentinel node biopsy – axillary dissection – breast reconstruction


Sources

1. Svobodník, A. Co je mamografický screening [on line]. [cit. 2007-06-06]. Dostupný z www: <http://www.mamo.cz/index.-php?s=mamograficky-screening>

2. Slade, M. J., Singh, A., Smith, B. M., et al. Persistence of bone marrow micrometastases in patients recieving adjuvant therapy for breast cancer: results at 4 years. Int. J. Cancer, 2005, roč. 114, č. 1, s. 94–100.

3. Morrow, M., Keeney, K., Scholtens, D., et al. Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer, 2006, roč. 106, č. 12, s. 2563–2568.

4. Chen, C. Y., Sun, L. M., Anderson, B. O. Paget disease of the breast: changing patterns of incidence, clinical presentation and treatment in the U.S. Cancer, 2006, roč. 107, č. 7, s. 1448–1458.

5. Tausch, C., Hintringer, T., Kugler, F., et al. Breast-conserving surgery with resection of the nipple-areola complex for subareolar breast carcinoma. Br. J. Surg., 2005, roč. 29, č. 11, s. 1368–1371.

6. McCulley, S. J., Durani, P., Macmillan, R. D. Therapeutic mammaplasty for centrally located breast tumors. Plast. Reconstr. Surg., 2006, roč. 117, č. 2, s. 366–373.

7. Cabioglu, N., Krishnamurthy, S., Kuerer, H. M., et al. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer, 2004, roč. 101, č. 3, s. 508–517.

8. Oh, J. L., Dryden, M. J., Woodward, W. A., et al. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J. Clin. Oncol., 2006, roč. 24, č. 31, s. 4971–4975.

9. Chen, A. M., Meric-Bernstam, F., Hunt, K. K., et al. Breast conservation after neoadjuvant chemotherapy. Cancer, 2005, roč. 103, č. 4, s. 689–695.

10. Gueth, U., Wight, E., Schoetzau, A., et al. Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features. J. Surg. Oncol., 2007, roč. 95, č. 4, s. 291–297.

11. Baron, L. F., Baron, P. L., Ackerman, S. J., et al. Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy. Am. J. Roentgenol., 2000, roč. 174, č. 2, s. 539–540.

12. Masetti, R., Di Leone, A., Franceschini, G., et al. Oncoplastic techniques in the conservative surgical treatment of breast cancer: an overview. Breast J., 2006, roč. 12, č.5, suppl. 2, s. 174–180.

13. Smitt, M. C., Nowels, K. W., Zdeblick, M. J., et al. The importance of the lumpectomy surgical margin in long-term results of breast conservation. Cancer, 1995, roč. 76, č. 2, s. 259–267.

14. Mc Intosh, A., Freedman, G., Eisenberg, D., Anderson, P. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am. J. Clin. Oncol., 2007, roč. 30, č. 2, s. 146–151.

15. Ben-David, M. A., Kleer, C. G., Paramaqul, C., et al. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis. Cancer, 2006, roč. 106, č. 1, s. 28–34.

16. Recht, A., Edge, S. B., Solin, L. J., et al. Postmastectomy radio-therapy: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol., 2001, roč. 19, č. 5, s. 1539–1569.

17. Bermejo-Pérez, M. J., Márques-Calderón, S., Llanos-Méndez, A. Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: A systematic review. Int. J. Cancer, 2007, roč. 121, č. 2, s. 225–231.

18. Arpino, G., Allred, D. C., Mohsin, S. K., et al. Lobular neoplasia on core-needle biopsy – clinical significance. Cancer, 2004, roč. 101, č. 2, s. 242–250.

19. Sacchini, V., Pinotti, J. A., Barros, A. C., et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J. Am. Coll. Surg., 2006, roč. 203, č. 5, s. 704–714.

20. Pačovský, Z., Fait, V. Initial experience with the fish-shaped incision in mastectomy. Rozhl. Chir., 1993, roč. 72, č. 3, s. 130–131.

21. Orr, R. K. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann. Surg. Oncol., 1999, roč. 6, č. 1, s. 109–116.

22. Cady, B. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J. Surg. Oncol., 1997, roč. 66, č. 1, s. 7–10.

23. Goyal, A., Douglas-Jones, A., Monypenny, I., et al. Is there role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res. Treat,, 2006, roč. 98, č. 3, s. 311–314.

24. Leidenius, M., Salmenkivi, K., von Smitten, K., et al. Tumor-positive sentinel node findings in patiens with ductal carcinoma in situ. J. Surg. Oncol., 2006, roč. 94, č. 5, s. 380–384.

25. Gajdos, C., Tartter, P. I., Bleiweiss, I. J., et al. The consequence of undertreating breast cancer in the elderly. J. Am. Coll. Surg., 2001, roč. 192, č. 6, s. 698–707.

26. Fleissig, A., Fallowfield, L. J., Langridge, C. I., et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res. Treat., 2006, roč. 95, č. 3, s. 279–293.

27. Radovanovic, Z., Golubovic, A., Plzak, A., et al. Blue dye versus combined blue dye – radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur. J. Surg. Oncol., 2004, roč. 30, č. 9, s. 913–917.

28. Rodier, J. F., Velten, M., Wilt, M., et al. Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial. JCO : Journal of Clinical Oncology [on-line]. 2007-05-07 [cit. 2007-06-15].12x ročně. Dostupný také z WWW: <http://jco.ascopubs.org/cgi/content/abstract/JCO.2006.08.4228v1>. ISSN: 1527-7755.

29. Hong, J., Choy, E., Soni, N., et al. Extra-axillary sentinel node biopsy in the management of early breast cancer. Eur. J. Surg. Oncol., 2005, roč. 31, č. 9, s. 942–948.

30. Filippakis, G. M., Zografos, G. Contraindications of sentinel lymph node biopsy: Are there any really? World J. Surg. Oncol., 2007, roč. 5, č. 10, s. 1–11.

31. Chung, M. H., Ye, W., Giuliano, A. E. Role for sentinel lymph node dissection in the management of large ( or = 5 cm) invasive breast cancer. Ann. Surg. Oncol., 2001, roč. 8, č. 9, s. 688–692.

32. Port, E. R., Garcia-Etienne, C. A., Park, J., et al. Reoperative Sentinel Lymph Node Biopsy: A New Frontier in the Management of Ipsilateral Breast Tumor Recurrence. ASO : Annals of Surgical Oncology [on-line]. 2007-02-01 [cit. 2007-06-15]. 12x ročně. Dostupný také z www: <http://www.springerlink.com/content/6103n44317443m88/?p=5f35e8b7dacc412b8c769623f79e3322&pi=0>. ISSN 1534-4681.

33. Intra, M., Veronesi, P., Gentilini, O. D., et al. Sentinel lymph node biopsy is feasible even after total mastectomy. J. Surg. Oncol., 2007, roč. 95, č. 2, s. 175–179.

34. Fait, V., Chrenko, V., Gatěk, J. Sentinelová biopsie u karcinomu prsu a neoadjuvantní chemoterapie. Klinická onkologie, 2005, roč. 18, č. 3, s. 77–79.

35. Coufal, O. Biopsie sentinelové uzliny u multifokálních a multicentrických karcinomů prsu. Klinická onkologie, 2007, roč. 20, v tisku.

36. Calhoun, K. E., Hansen, N. M., Turner, R. R., Giuliano, A. E. Nonsentinel node metastase in breast cancer patiens with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am. J. Surg., 2005, roč. 190, č. 4, s. 588–591.

37. Lyman, G. H., Giuliano, A. E., Somerfield, M. R., et al. American Society of Clinical Oncology guideline recommendations for sentinel node biopsy in early-stage breast cancer. J. Clin. Oncol., 2005, roč. 23, č. 30, s. 7703–7720.

38. Park, J., Fey, J. V., Naik, A. M., et al. A declining rate of completion axillary dissection in sentinel lymph node positive breast cancer patients is associated with the use of a multivariate nomogram. Ann. Surg., 2007, roč. 245, č. 3, s. 462–468.

39. van Rijk, M. C., Tanis, P. J., Nieweg, O. E., et al. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J. Surg. Oncol., 2006, roč. 94, č. 4, s. 281–286.

40. Forrest, A. P., Everington, D., McDonald, C. C., et al. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br. J. Surg., 1995, roč. 82, č. 11, s. 1504–1508.

41. Macmillan, R. D., Barbera, D., Hadjiminas, D. J., et al. Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. Results of a prospective comparison study. Eur. J. Cancer, 2001, roč. 37, č. 9, s. 1076–1080.

42. Agarwal, T., Kakkos, S. K., Cunningham, D. A., et al. Sentinel node biopsy can replace four-node-ampling in staging early breast cancer. Eur. J. Surg. Oncol., 2005, roč. 31, č. 2, s. 122–127.

43. Moore, M. P., Kinne, D. W. Is axillary node dissection necessary in the routine management of breast cancer? Yes. Important Adv. Oncol., 1996; s. 245–250.

44. Cordeiro, P. G., Pusic, A. L., Disa, J. J., et al. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast. Reconstr. Surg., 2004, roč. 113, č. 3, s. 877–881.

45. Tran, N. V., Chang, D. W., Gusta, A., et al. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast. Reconstr. Surg., 2001, roč. 108, č. 1, s. 78–82.

Labels
Surgery Orthopaedics Trauma surgery
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#